...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF

+ average down that .36/share u pay with the free one you were given ta boot.

I just find it hard to believe that there still selling so cheap given all the Pharmas envolved , success thus far & two years of hearing buyout rumours-u can sell your r v x & pretty much get two zen shr's for one - doesn't make any sense or does it??? Sure some buying but quite brutal for the most part - most folks appear quite shy to take advantage of what seems to be a fantastic deal
it just seems to good to be true , mind u no rumours hav every come true - maybe years away form a deal.....??? 
odd either way IMO

Share
New Message
Please login to post a reply